{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "AIP",
  "name": "Arteris, Inc.",
  "url": "https://orbyd.app/dossiers/AIP/",
  "json_url": "https://orbyd.app/dossiers/AIP.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Semiconductor-IP royalty re-accel (Q1 variable royalties +67% YoY, FY26 guide raised to $91-95M) is fundamentally intact, but a $48.59 blowoff top (6/30) reversed ~29% and closed back below the ~$39 breakout shelf. Momentum leg is broken; the ~2026-08-04 Q2 print is the binary. Little edge in a fresh long into a broken chart a week and a half ahead of it.",
  "invalidation_trigger": "A weekly close below $33 breaks the early-July reaction low (~$32-34) and turns the blowoff-top reversal into a full trend break; secondarily, a Q2 print (~2026-08-04) showing variable royalties decelerating below +25% YoY versus +67% in Q1.",
  "catalyst_date": "2026-08-04",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-chips-memory"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "2026-06-12: +11.9% session cleared the $38.99 prior ATH; ran to $44.94 high by 2026-06-15. The breakout the prior structure was waiting for has triggered — now trading above every analyst PT ($35–$40).",
    "Correlated with the large-cap AI-semi complex (TSMC/NVDA/AVGO/Marvell/HBM) — levers the same beta, does not diversify it. Higher volatility due to small float.",
    "Theme registry: Arteris is a fabless semiconductor NoC-interconnect IP company; any residual 'commodity-materials' seeding is incorrect.",
    "Theme registry: Arteris is a fabless semiconductor-IP company (NoC interconnect), NOT commodity-materials — any residual 'commodity-materials' seeding is wrong; canonical membership narrowed to ai-chip-infra-memory on 2026-07-01.",
    "Q2 date is ESTIMATED (~2026-08-04) off the 2026-05-12 Q1 print cadence; could slip to early-to-mid August. Hard no-new-entry window opens ~3 trading days before the actual print — a fresh long inside it is an earnings gamble, off-playbook.",
    "KPI to watch is the variable-royalty line, not headline revenue: +67% YoY in Q1; any deceleration below +25% YoY on a future print is thesis-breaking.",
    "Small float (~44M shares, ~$1.5-1.6B cap) → gappy tape; single -7% to -8% sessions are normal volatility, not signal. Size conservatively even on a clean post-print re-entry.",
    "Correlated cluster risk with the large-cap AI-semi complex (NVDA/TSMC/Broadcom/Marvell/HBM) — AIP amplifies that beta, it does not diversify it.",
    "Re-rated from ~$19.56 (early April) to a $48.59 closing ATH (6/30); the 'undiscovered small-cap' edge is gone — this is a quality-continuation read priced near the ~$37.75 average sell-side target, not a hidden gem."
  ],
  "body_markdown": "## Current Thesis\nArteris licenses the network-on-chip (NoC) interconnect IP that stitches the compute blocks inside modern SoCs together, and collects a per-unit variable royalty each time a licensed chip ships. Royalties trail design wins by roughly 18-24 months, so the 2023-24 custom-silicon and ADAS win wave is only now converting to revenue. Q1 2026 (reported 2026-05-12) confirmed the inflection: revenue $22.9M (+39% YoY, ~8% above the ~$21M consensus), variable royalties +67% YoY, ACV+royalties $92.8M (+39%), RPO $118.3M (+33%), and a raised FY26 guide of $91-95M with positive free cash flow. The fundamental story is accelerating.\n\nThe tape is the problem. Price ran that inflection vertically to a $48.59 closing ATH (2026-06-30), then reversed ~29% in a week and closed back below the ~$39 shelf it had broken out from. That failed breakout leaves the momentum leg broken while the Q2 print (~2026-08-04, est.) sits roughly a week and a half out. A fresh long here buys a broken structure into a binary royalty print with little reward for the timing risk. The setup is a pass until the name either repairs a base and reclaims ~$39, or delivers a clean post-print continuation.\n\n## Bull Case\n- **Q1 2026 (2026-05-12): revenue $22.9M, +39% YoY**, ~8% above the ~$21M consensus, EPS -$0.03 vs -$0.09 expected — a clean beat and an acceleration off the FY25 +22% pace.\n- **Variable royalties +67% YoY in Q1** — the lead KPI accelerated hard, the strongest evidence that prior design wins are converting to shipped chip volume. This single line carries the thesis.\n- **ACV + royalties $92.8M (+39%), RPO $118.3M (+33%)** — contracted backlog grew in step with revenue, giving the acceleration forward visibility rather than a one-quarter pop.\n- **FY26 guide raised to $91-95M with positive FCF; Q2 guide $23-24M** — a beat-and-raise quarter guiding to continued sequential growth.\n- **Design-win cadence keeps landing:** the 2026-07-14 Arm partnership expansion (security assurance for processor-core development) deepens ecosystem lock-in, stacking on late-June SiEngine FlexNoC licensing for a next-gen automotive SoC, the June Li Auto L9 win, and Q1-call wins spanning a global hyperscaler, a top HBM supplier, a MIPS physical-AI collaboration, and NoC IP on NASA Artemis.\n- **Sell-side re-rated up through Q2:** TD Cowen $40 (from $22), Rosenblatt $38 Buy (from $20), Northland $38, Jefferies $35 (from $16); consensus Buy, ~$37.75 average target.\n\n## Bear Case\n- **The breakout failed.** After the $48.59 closing ATH (2026-06-30), price collapsed ~29% in a week and closed back under the ~$39 shelf it launched from. Losing the base a breakout was built on is a structural break, not a routine pullback.\n- **The top was a one-week blowoff.** A +11.9% spike to fresh highs (2026-06-12) followed two weeks later by -10.7% and -16.4% sessions is parabolic exhaustion; anchoring to the old $48 high after that reversal is the classic chase trap.\n- **Binary print into a broken chart.** With the Q2 report ~2026-08-04, the whole thesis reduces to one line — variable-royalty growth. Any deceleration below +25% YoY (versus +67% in Q1) re-rates the multiple down hard, and it lands while the chart offers no structural support beneath price.\n- **Insider selling into the run** during the June melt-up, plus CFO Nicholas Hawkins retiring 2026-08-31 (announced 2026-05-08) with no named successor yet — a leadership-transition overhang.\n- **Valuation caught up.** At the ~$36-37 area the stock trades near the ~$37.75 average sell-side target; the \"undiscovered small-cap\" edge that existed at ~$19.56 in early April is gone. Execution is now priced in.\n- **Small float (~44M shares, ~$1.5-1.6B cap)** produces gappy tape that cuts both ways; the violence of the reversal is a feature of the structure.\n\n## Setup & Price Structure\nThe structure is in a post-blowoff repair phase. Reference levels from the June-July action: the $48.59 closing ATH (2026-06-30) is the anchor high; the ~$39 breakout shelf is now overhead resistance that has to be reclaimed to repair the trend; the early-July reaction low sits near $32-34. The late-week bounce to ~$36.61 (2026-07-10) into the mid-$30s read as short-covering and dip-testing rather than a confirmed higher-low base. Price since then needs re-validation against the current tape, but the map holds: under ~$39 the name is basing or broken, and a weekly close below $33 breaks the July reaction low and converts the reversal into a full trend break. A constructive re-entry needs a higher low above the low-$30s and a reclaim of $39 on expanding volume — better taken as a post-print continuation than a pre-print guess. RSI ran hot into the June top and the flush has worked off that excess, leaving the name neither an oversold bounce nor breakout-clean here.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-31: CFO Nicholas Hawkins retirement** (announced 2026-05-08). A successor announcement ahead of this date is a watch item — transition clarity or continued overhang.\n- No FDA/regulatory or index-rebalance events pending inside the window.\n\n## Elapsed catalysts\n\n- **~2026-08-04 (est.): Q2 2026 earnings** — the binary. Watch variable royalties (+67% YoY in Q1; deceleration below +25% YoY is thesis-breaking), the FY26 guide ($91-95M) revision, and Q2 revenue against the $23-24M guide. Cadence is estimated off the 2026-05-12 Q1 print, so the date could slip to early-to-mid August. *(passed 5d ago)*\n- **2026-07-14 (just passed): Arm partnership expansion** for processor-core security assurance — incremental ecosystem-integration datapoint, not a standalone price catalyst. *(passed 26d ago)*\n\n## What Would Change Our Mind\n- **Turns constructive:** a higher low that holds above the low-$30s followed by a weekly close back above $39 on expanding volume, ideally confirmed by a Q2 print keeping variable royalties above +40% YoY. That repairs the structure and re-opens a momentum-continuation entry.\n- **Confirms the break:** a weekly close below $33 breaks the July reaction low; separately, a Q2 variable-royalty line below +25% YoY breaks the fundamental thesis independent of the chart.\n- **Stays noise:** single -7% to -8% sessions on ~44M-share float are normal volatility for this name and do not by themselves change the read.\n\n## Correlation Notes\nArteris levers the same AI-semiconductor beta as the large-cap complex (NVDA, TSMC, Broadcom, Marvell) and the HBM/custom-silicon supply chain — it amplifies that exposure, it does not diversify it. Royalties are a downstream, lagged read on unit shipments across that ecosystem, so a broad AI-capex or custom-silicon-demand wobble reaches AIP with a delay and with more torque given the small float. Automotive/ADAS design wins (Li Auto, SiEngine) add a second-order tie to the China auto-silicon cycle. Any AIP exposure should be treated as concentrated AI-semi risk, correlated with existing large-cap chip names rather than additive to them.",
  "first_seen": "2026-04-20",
  "last_analyzed": "2026-07-26T11:28:22+00:00",
  "last_synthesized": "2026-07-26",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}